AllianceBernstein’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $703M | Sell |
5,729,225
-167,075
| -3% | -$23.4M | 0.23% | 84 |
|
|
2025
Q4 | $724M | Buy |
5,896,300
+9,723
| +0.2% | +$1.18M | 0.23% | 83 |
|
|
2025
Q3 | $653M | Sell |
5,886,577
-258,213
| -4% | -$29.3M | 0.21% | 84 |
|
|
2025
Q2 | $681M | Sell |
6,144,790
-809,531
| -12% | -$86.2M | 0.22% | 80 |
|
|
2025
Q1 | $779M | Sell |
6,954,321
-93,525
| -1% | -$9.65M | 0.28% | 68 |
|
|
2024
Q4 | $651M | Buy |
7,047,846
+50,434
| +0.7% | +$4.54M | 0.22% | 84 |
|
|
2024
Q3 | $587M | Buy |
6,997,412
+320,044
| +5% | +$24.4M | 0.2% | 92 |
|
|
2024
Q2 | $458M | Sell |
6,677,368
-301,300
| -4% | -$20.1M | 0.16% | 108 |
|
|
2024
Q1 | $511M | Sell |
6,978,668
-287,847
| -4% | -$22.1M | 0.18% | 108 |
|
|
2023
Q4 | $589M | Buy |
7,266,515
+64,689
| +0.9% | +$5.03M | 0.23% | 90 |
|
|
2023
Q3 | $540M | Sell |
7,201,826
-155,991
| -2% | -$12M | 0.23% | 87 |
|
|
2023
Q2 | $567M | Buy |
7,357,817
+371,998
| +5% | +$29.7M | 0.23% | 87 |
|
|
2023
Q1 | $580M | Buy |
6,985,819
+3,096,039
| +80% | +$256M | 0.25% | 90 |
|
|
2022
Q4 | $334M | Buy |
3,889,780
+2,101,626
| +118% | +$166M | 0.15% | 135 |
|
|
2022
Q3 | $110M | Buy |
1,788,154
+27,918
| +2% | +$1.76M | 0.05% | 329 |
|
|
2022
Q2 | $109M | Buy |
1,760,236
+101,996
| +6% | +$6.31M | 0.05% | 344 |
|
|
2022
Q1 | $98.6M | Buy |
1,658,240
+13,997
| +0.9% | +$895K | 0.04% | 408 |
|
|
2021
Q4 | $119M | Sell |
1,644,243
-50,806
| -3% | -$3.5M | 0.04% | 389 |
|
|
2021
Q3 | $118M | Sell |
1,695,049
-162,101
| -9% | -$11.4M | 0.05% | 379 |
|
|
2021
Q2 | $128M | Sell |
1,857,150
-246,438
| -12% | -$16.5M | 0.05% | 350 |
|
|
2021
Q1 | $136M | Buy |
2,103,588
+252,298
| +14% | +$16.3M | 0.06% | 311 |
|
|
2020
Q4 | $108M | Sell |
1,851,290
-151,527
| -8% | -$9.14M | 0.05% | 361 |
|
|
2020
Q3 | $127M | Sell |
2,002,817
-275,247
| -12% | -$19.1M | 0.07% | 258 |
|
|
2020
Q2 | $175M | Buy |
2,278,064
+23,747
| +1% | +$1.82M | 0.1% | 171 |
|
|
2020
Q1 | $169M | Sell |
2,254,317
-4,701,747
| -68% | -$325M | 0.12% | 156 |
|
|
2019
Q4 | $452M | Sell |
6,956,064
-1,943,346
| -22% | -$127M | 0.26% | 88 |
|
|
2019
Q3 | $564M | Sell |
8,899,410
-2,253,764
| -20% | -$147M | 0.35% | 58 |
|
|
2019
Q2 | $754M | Buy |
11,153,174
+44,302
| +0.4% | +$2.91M | 0.47% | 47 |
|
|
2019
Q1 | $722M | Sell |
11,108,872
-132,660
| -1% | -$8.82M | 0.47% | 47 |
|
|
2018
Q4 | $703M | Buy |
11,241,532
+650,280
| +6% | +$45.5M | 0.52% | 42 |
|
|
2018
Q3 | $818M | Buy |
10,591,252
+241,790
| +2% | +$18.3M | 0.53% | 37 |
|
|
2018
Q2 | $733M | Buy |
10,349,462
+390,460
| +4% | +$27.6M | 0.51% | 38 |
|
|
2018
Q1 | $751M | Buy |
9,959,002
+56,369
| +0.6% | +$4.48M | 0.54% | 32 |
|
|
2017
Q4 | $709M | Sell |
9,902,633
-149,861
| -1% | -$11.4M | 0.51% | 36 |
|
|
2017
Q3 | $814M | Sell |
10,052,494
-884,070
| -8% | -$67.6M | 0.61% | 20 |
|
|
2017
Q2 | $774M | Sell |
10,936,564
-559,878
| -5% | -$37.3M | 0.6% | 26 |
|
|
2017
Q1 | $781M | Sell |
11,496,442
-291,870
| -2% | -$20.5M | 0.62% | 27 |
|
|
2016
Q4 | $844M | Buy |
11,788,312
+69,280
| +0.6% | +$5.15M | 0.7% | 22 |
|
|
2016
Q3 | $927M | Sell |
11,719,032
-1,627,682
| -12% | -$132M | 0.78% | 17 |
|
|
2016
Q2 | $1.11B | Buy |
13,346,714
+1,942,138
| +17% | +$172M | 0.96% | 13 |
|
|
2016
Q1 | $1.05B | Sell |
11,404,576
-555,527
| -5% | -$50.1M | 0.89% | 15 |
|
|
2015
Q4 | $1.21B | Sell |
11,960,103
-54,833
| -0.5% | -$5.71M | 1.03% | 9 |
|
|
2015
Q3 | $1.18B | Buy |
12,014,936
+347,699
| +3% | +$38.6M | 1.01% | 10 |
|
|
2015
Q2 | $1.37B | Buy |
11,667,237
+27,293
| +0.2% | +$2.98M | 1.13% | 6 |
|
|
2015
Q1 | $1.14B | Buy |
11,639,944
+1,675,333
| +17% | +$170M | 0.93% | 11 |
|
|
2014
Q4 | $939M | Sell |
9,964,611
-850,106
| -8% | -$87.9M | 0.78% | 16 |
|
|
2014
Q3 | $1.15B | Sell |
10,814,717
-1,882,616
| -15% | -$184M | 0.97% | 9 |
|
|
2014
Q2 | $1.05B | Buy |
12,697,333
+3,235,502
| +34% | +$252M | 0.89% | 12 |
|
|
2014
Q1 | $670M | Buy |
9,461,831
+2,044,699
| +28% | +$160M | 0.58% | 26 |
|
|
2013
Q4 | $557M | Buy |
7,417,132
+164,764
| +2% | +$11.5M | 0.5% | 42 |
|
|
2013
Q3 | $456M | Buy |
7,252,368
+6,436
| +0.1% | +$385K | 0.45% | 48 |
|
|
2013
Q2 | $371M | Buy |
+7,245,932
| New | +$378M | 0.39% | 61 |
|
Other funds holding GILD
VCM
VPM
AllianceBernstein's GILD Position: Q1 2026 in Review
AllianceBernstein reduced its Gilead Sciences (GILD) stake by 2.8% in Q1 2026, selling an estimated $23.4M and leaving 5,729,225 shares worth $703M. The position accounts for 0.23% of the portfolio, ranked #84.
AllianceBernstein first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.37B in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- AllianceBernstein held 5,729,225 shares of Gilead Sciences worth $703M as of Q1 2026.
- AllianceBernstein sold 167,075 Gilead Sciences shares in Q1 2026, an estimated $23.4M.
- Gilead Sciences made up 0.23% of AllianceBernstein's portfolio in Q1 2026, its #84 holding.
- AllianceBernstein first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- AllianceBernstein's Gilead Sciences position peaked at $1.37B in Q2 2015.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.